Le mode conseil est activé Arrêter
Pour la navigation rapide entre les blocs

Organisation: Illumina
LEI SQ95QG8SR5Q56LSNF682

Nom de l'organisation
Illumina Inc
Nom du pays
États-Unis
Pays d'enregistrement
États-Unis
Secteur économique
Equipement médical
Dette obligataire
1.500 millions USD

explorer la base de données la plus complète

800 000

obligations globalement

Plus de 400

sources de prix

80 000

actions

9 000

ETF

suivre votre portefeuille de la manière la plus efficace
screener d'obligations
liste de surveillance
Excel ADD-IN
Obtenir l'accès

Dernières données pour

Cotations

Requête envoyé
Accès refusé
Envoyer la requête
Les cotations fournis par les fournisseurs d’information sont de nature indicative

Profile

Illumina, Inc. (Illumina) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function. The Company provides a line of genetic analysis solutions, with products and services that serve a range of interconnected markets, including sequencing, genotyping, gene expression, and molecular diagnostics. The Company is organized in two business segments: Life Sciences and Diagnostics. Its Life Sciences business unit includes all products and services related to the research market, namely the product lines based on its sequencing, BeadArray, VeraCode, and real-time PCR technologies. Its Diagnostics business unit focuses on molecular diagnostics. Its customers include genomic research centres, academic institutions, government laboratories, and clinical research organizations.

Récompenses

Actualités

22/04/2024 S&P Global Ratings affirms Illumina at "BBB" (Local Currency LT credit rating); outlook stable
22/04/2024 S&P Global Ratings affirms Illumina at "BBB" (Foreign Currency LT credit rating); outlook stable
12/04/2024 Illumina: Regulation Fd Disclosure
04/04/2024 Illumina: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Regulation Fd Disclosure, Financial Statements And Exhibits
09/01/2024 Illumina: Results Of Operations And Financial Condition, Financial Statements And Exhibits
Toutes les actualités de l'organisation

Documents

Etats financiers IFRS / US GAAP

2023
I q ang
II q ang
III q ang
IV q ang
2022
I q ang
II q ang
III q ang
IV q ang
2021
I q ang
II q ang
III q ang
IV q ang
2020
I q ang
II q ang
III q ang
IV q ang
2019
I q ang
II q ang
III q ang
IV q ang
2018
I q ang
II q ang
III q ang
IV q ang
2017
I q ang
II q ang
III q ang
IV q ang
2016
I q ang
II q ang
III q ang
IV q ang
2015
I q ang
II q ang
III q ang
IV q ang
2014
IV q ang
Afficher tout Masquer
Il faut s'enregistrer
Envoyer la demande d'accès accès

Actions

Dernières émissions

Montrer tout

Dette obligataire par devise

Montrer tout Cacher

Codes

  • LEI
    SQ95QG8SR5Q56LSNF682
  • SIC
    3826 LABORATORY ANALYTICAL INSTRUMENTS
  • ICB
    4.500 Health Care
  • CIK
    0001110803
  • EIN
    33-0804655

Notations de crédit et notations d’ESG

Macroéconomie

Vous devez vous inscrire pour y accéder.